针对心力衰竭的指导医疗疗优化的协议驱动方法:恢复的现实应用
Crystal Lihong Yan1, David Snipelisky2, Mauricio Velez2
1Divison of Internal Medicine, University of Miami Health System, Miami, FL, USA.
American heart journal plus : cardiology research and practice
|September 2, 2024
概括
一个积极的指导方针导向医学治疗 (GDMT) 方案显著改善了心力衰竭与减少喷射率 (HFrEF) 的结果. 这种个性化的方法提高了左心室喷射率 (LVEF),减少了住院治疗,并降低了现实世界心力衰竭患者的死亡率.
科学领域:
- 心脏病学 心脏病学
- 心脏衰竭研究研究
- 临床药理学 临床药理学
背景情况:
- 指南导向医学疗法 (GDMT) 对于治疗心力衰竭 (HF) 至关重要.
- 在心力衰竭患者中优化GDMT定位与减少喷射分数 (HFrEF) 仍然是一个临床挑战.
- 对积极的,个性化的GDMT协议的现实数据对于改善患者的治疗结果至关重要.
研究的目的:
- 为了评估在HFrEF患者中积极的,个性化的GDMT定位协议的现实世界的有效性.
- 评估该协议对左心室喷射率 (LVEF) 的影响,纽约心脏协会 (NYHA) 的分类,住院和死亡率.
主要方法:
- 一个双中心的回顾性队列研究.
- 180名HFrEF患者在2020年1月至2022年12月期间接受GDMT协议治疗.
- 分析GDMT得分,LVEF,NYHA分类以及住院和死亡率的变化.
主要成果:
- 平均GDMT得分 (4.7至5.9,p < 0.001) 和LVEF (28%至33%,p < 0.001) 的显著增加.
- 15.7%的患者在NYHA类中表现出改善,77.8%的患者没有意外住院.
- 死亡率 (3.9%) 低于预期 (12.3%);由于药物不良事件而导致的住院病例很少.
结论:
- 一个积极的,个性化的GDMT定位方案在现实环境中显著改善了HFrEF患者的临床结果.
- 该方案在LVEF,NYHA类,减少住院治疗和降低死亡率方面取得了改进.
- 研究结果表明,该方案可以弥合临床知识和实践之间的差距,以优化HFrEF中的GDMT.
更多相关视频
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
733
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.5K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
404
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
01:26Heart Failure Drugs: Inotropic Agents
545
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
545
01:22Heart Failure Drugs: Diuretics
352
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:22Heart Failure Drugs: β-Blockers
322
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
322
01:10Pre-Procedural Guidelines for Assessing Blood Pressure
526
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
526